# Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)

Study · id `cardio:ct-nct01870804` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01870804](<https://clinicaltrials.gov/study/NCT01870804>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01870804

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 760 participants.

## Technical summary

Registry record NCT01870804. Randomized; double masking; primary purpose prevention. Start 2013-05 (registry gives no type); primary completion 2016-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 760 participants (enrolled count; ClinicalTrials.gov record NCT01870804, source copy `cardio:ctgov-nct01870804-2016-10-06`, retrieved 2026-10-31)
- Start date: 2013-05 (registry gives no type) (ClinicalTrials.gov record NCT01870804, source copy `cardio:ctgov-nct01870804-2016-10-06`, retrieved 2026-10-31)
- Primary completion: 2016-07 (actual) (ClinicalTrials.gov record NCT01870804, source copy `cardio:ctgov-nct01870804-2016-10-06`, retrieved 2026-10-31)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT01870804, source copy `cardio:ctgov-nct01870804-2016-10-06`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT01870804, source copy `cardio:ctgov-nct01870804-2016-10-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01870804-2016-10-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)
- Acronym: PRATO-ACS-2
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Rosuvastatin
- Intervention (Drug): Atorvastatin
- Lead sponsor: Centro Cardiopatici Toscani
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study (`cardio:pubmed-32434204`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 472f58b03134dd6b597424b483d2f6c202e19ffb4e2b4df4d5e6891b099ab9d3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
